mRNA |
salermide |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.05 |
mRNA |
LY-2183240 |
CTRPv2 |
pan-cancer |
AAC |
0.063 |
0.05 |
mRNA |
rigosertib |
CTRPv2 |
pan-cancer |
AAC |
0.065 |
0.05 |
mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
-0.074 |
0.05 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
0.058 |
0.05 |
mRNA |
BRD-K09587429 |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.05 |
mRNA |
SR1001 |
CTRPv2 |
pan-cancer |
AAC |
-0.074 |
0.05 |
mRNA |
Tamoxifen |
CTRPv2 |
pan-cancer |
AAC |
-0.073 |
0.05 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.05 |
mRNA |
Gefitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.07 |
0.05 |